Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds
NCT ID: NCT00686296
Last Updated: 2015-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2008-12-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obtaining and Storing Wound Debridment Samples For Immediate or Future Wound-Related Scientific Study
NCT00759499
Dermal Suturing Only Versus Layered Cutaneous Closure
NCT02383186
Obtaining and Storing Blood Samples and Debridement Samples for Wound Related Research
NCT00762697
A Open Study to Evaluate the Performance of Dressing on Subject With High Risk of Skin Breakdown
NCT01354899
A Comparison Between Two Post-operative Dressings
NCT04888624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group II
Taliderm™ dressing applied until the next scheduled dressing change (up to eight hours), then replaced by a gauze dressing. Gauze dressing changes will continue per standard of care until the scheduled follow-up visits (first or second visit). At the scheduled follow-up visits, the subject will have a Taliderm™ dressing applied and left in place until the next scheduled dressing change (up to eight hours), then will continue standard of care wet to dry gauze dressing changes until next scheduled follow-up visit.
Taliderm™
Taliderm™ dressing application up to three applications
III
standard wet to dry dressing with gauze
standard wet to dry dressing with gauze
wet to dry dressing standard of care
group I
Taliderm™ dressing applied until the next scheduled dressing change (up to eight hours), then replaced by a gauze dressing
Taliderm™
taliderm™ dressing application once
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Taliderm™
taliderm™ dressing application once
Taliderm™
Taliderm™ dressing application up to three applications
standard wet to dry dressing with gauze
wet to dry dressing standard of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wound will require serial dressing changes
* Greater than or equal to 18 years of age
* Ability to obtain informed consent
Exclusion Criteria
* Pregnancy
* Prisoner
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center at San Antonio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John G Myers, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center at San Antonio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-2007-0709-H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.